Michael W. Bonney
CHAIRMAN
Bussiness Development
Alnylam
Switzerland
Biography
Former Chief Executive Officer and Director of Cubist Pharmaceuticals and former Partner of Third Rock Ventures; Director of Celgene Corporation, Global Blood Therapeutics, Inc., and Revolution Medicines, Inc.; and Trustee of Gulf of Maine Research Institute and Tekla fund complex, focused on healthcare investing.
Research Interest
Business Development and Management
